Cargando…
Diagnostic performance of Oncuria™, a urinalysis test for bladder cancer
BACKGROUND: Due to insufficient accuracy, urine-based assays currently have a limited role in the management of patients with bladder cancer. The identification of multiplex molecular signatures associated with disease has the potential to address this deficiency and to assist with accurate, non-inv...
Autores principales: | Hirasawa, Yosuke, Pagano, Ian, Chen, Runpu, Sun, Yijun, Dai, Yunfeng, Gupta, Amit, Tikhonenkov, Sergei, Goodison, Steve, Rosser, Charles J., Furuya, Hideki |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8025333/ https://www.ncbi.nlm.nih.gov/pubmed/33823873 http://dx.doi.org/10.1186/s12967-021-02796-4 |
Ejemplares similares
-
Influencing Factors on the Oncuria™ Urinalysis Assay: An Experimental Model
por: Murakami, Kaoru, et al.
Publicado: (2021) -
Application of a multiplex urinalysis test for the prediction of intravesical BCG treatment response: A pilot study
por: Murakami, Kaoru, et al.
Publicado: (2022) -
Bladder cancer risk stratification with the Oncuria 10-plex bead-based urinalysis assay using three different Luminex xMAP instrumentation platforms
por: Furuya, Hideki, et al.
Publicado: (2023) -
Clinical Utility of Oncuria™, a Multiplexed Liquid Biopsy for the Non-Invasive Detection of Bladder Cancer—A Pilot Study
por: Murakami, Kaoru, et al.
Publicado: (2022) -
A Diagnostic Gene Expression Signature for Bladder Cancer Can Stratify Cases into Prescribed Molecular Subtypes and Predict Outcome
por: Chen, Runpu, et al.
Publicado: (2022)